NRXN3 and psychiatric disorder: NRXN3 [1242–1254] was significantly downregulated in the CSF of all studied psychiatric disorder groups (MDD: p < 0.01, BI: p < 0.01, SCZ: p < 0.05) in comparison to the control group (Fig. 3).